Clinical Trial Update: Effect of Additional Clofazimine on Erythema Nodosum Leprosum (ENL) Reactions in Leprosy [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether adding extra clofazimine reduces erythema nodosum leprosum reactions in leprosy patients; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leprosy

Drugs mentioned

• Clofazimine (clofazimine)

Snippet

Sponsor: Paul Saunderson | Conditions: Borderline Lepromatous Leprosy, Lepromatous Leprosy | Phase 4 | Status: COMPLETED